Skip to main navigation

About Us
Our Approach
& Programs
Patients
& Caregivers
For Investors
& Media
Join
Our Team
- Who We Are
- Benefits
- Join Us
- Awards
Contact

About Us
Our Approach
& Programs
Patients
& Caregivers
For Investors
& Media
Join
Our Team
- Who We Are
- Benefits
- Join Us
- Awards
Contact

Investors & Media

Investor Overview
Stock Information
- Stock Quote
- Stock Chart
Press Releases
Events and Presentations
Corporate Governance
Financial Information
- SEC Filings
Annual Reports
Analyst Coverage
Investor FAQs
Contact Us

Press Releases

Keyword Search

Year

Apr 28, 2021

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2021 Annual Meeting

Apr 26, 2021

Voyager Therapeutics Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease

Feb 25, 2021

Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates

Feb 18, 2021

Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference

Feb 2, 2021

Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program

Jan 11, 2021

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Print Page
RSS Feeds
Share Page
X
- Share on:
- Facebook
- Twitter
- LinkedIn
- Google+
- Reddit
- Digg
- Google
- Delicious
- StumbleUpon
E-mail Alerts
IR Contacts

Data provided by Nasdaq. Minimum 15 minutes delayed.

About Us
Our Approach
& Programs
Patients
& Caregivers
For Investors
& Media
Join Our
Team
Contact

© Voyager Therapeutics All rights served.

LinkedIn
Terms of Use
Sitemap